Condition: Atrial Fibrillation · Stroke · Bleeding · Sponsor: Boston Scientific Corporation
The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Grandview Medical Center | Birmingham, Alabama, United States | — |
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Arizona Arrhythmia Research Center | Phoenix, Arizona, United States | — |
| Phoenix Cardiovascular Research Group | Phoenix, Arizona, United States | — |
| Scottsdale Healthcare - Shea | Scottsdale, Arizona, United States | — |
| Tucson Medical Center Healthcare | Tucson, Arizona, United States | — |
| Arrythmia Research Group | Jonesboro, Arkansas, United States | — |
| Sharp Chula Vista Medical Center | Chula Vista, California, United States | — |
| Marin General Hospital | Greenbrae, California, United States | — |
| Scripps Memorial Hospital | La Jolla, California, United States | — |
| Los Robles Hospital and Medical Center | Los Angeles, California, United States | — |
| El Camino Hospital | Mountain View, California, United States | — |
+ 129 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.